Dravet syndrome (DS), also known as severe myoclonic epilepsy of infancy (SMEI), is a rare genetic disorder that results in severe childhood-onset epilepsy. Children with DS initially present with seizures in the first year of life that are often associated with fevers. With age, multiple seizure types develop. There are few reports and no guidelines regarding palliative surgical treatment for DS. Therefore, we reviewed our surgical experience with DS.
We conducted a retrospective review of all patients with genetically confirmed DS who underwent either vagal nerve stimulator (VNS) implantation or corpus callosotomy (CC) from May 2001 to April 2014 at our institution. All inpatient and outpatient relevant documentation were reviewed. Demographic information, genetic mutation, operation performed, and preoperative and postoperative seizure frequency were recorded. Inclusion criteria required greater than one-year postoperative follow-up.
Seven children with DS were assessed. Six patients were treated with VNS and one patient was treated with CC. In one child, VNS was followed by CC as a secondary procedure. Therefore, in total, eight surgeries were performed on seven patients during the study period. At least 1 year elapsed from presentation to our hospital and surgery for all patients. Average time after the first seizure to VNS was 4.1 years, and the average time after the first seizure to CC was 7.6 years. The mean age of patients undergoing VNS implantation was 4.3 years, and the mean age for patients undergoing CC was eight. Average follow-up for all seven patients was 6.6 years. Seizures were decreased in five of the six patients with VNS and decreased in the two patients after CC. Four of the six patients who had VNS implanted had a greater than 50 % reduction in seizure frequency, and one of the six patients who had VNS implanted had a less than 50 % reduction in seizure frequency. One patient did not respond effectively to the VNS and had very limited change in seizure frequency. Both patients who had a CC had a greater than 50 % reduction in seizure frequency.
Both VNS and CC in patients with DS can be effective at reducing seizure frequency. Patients with DS may benefit from earlier and more aggressive surgical intervention. Studies using larger patient cohorts will help clarify the role that surgery may play in the multidisciplinary approach to controlling seizures in DS. Further studies will help determine the appropriate timing of and type of surgical intervention.
This is a preview of subscription content, access via your institution.
Buy single article
Instant access to the full article PDF.
Tax calculation will be finalised during checkout.
Dravet C, Oguni H (2013) Dravet syndrome (severe myoclonic epilepsy in infancy). Handb Clin Neurol 111:627–633
Dravet C (2000) Severe myoclonic epilepsy in infants and its related syndromes. Epilepsia 41(Suppl 9):7
Kalume F (2013) Sudden unexpected death in Dravet syndrome: respiratory and other physiological dysfunctions. Respir Physiol Neurobiol 189:324–328
Genton P, Velizarova R, Dravet C (2011) Dravet syndrome: the long-term outcome. Epilepsia 52(Suppl 2):44–49
Ragona F, Brazzo D, De Giorgi I, Morbi M, Freri E, Teutonico F, Gennaro E, Zara F, Binelli S, Veggiotti P, Granata T (2010) Dravet syndrome: early clinical manifestations and cognitive outcome in 37 Italian patients. Brain Dev 32:71–77
Wolff M, Casse-Perrot C, Dravet C (2006) Severe myoclonic epilepsy of infants (Dravet syndrome): natural history and neuropsychological findings. Epilepsia 47(Suppl 2):45–48
Claes L, Del-Favero J, Ceulemans B, Lagae L, Van Broeckhoven C, De Jonghe P (2001) De novo mutations in the sodium-channel gene SCN1A cause severe myoclonic epilepsy of infancy. Am J Hum Genet 68:1327–1332
Zuberi SM, Brunklaus A, Birch R, Reavey E, Duncan J, Forbes GH (2011) Genotype-phenotype associations in SCN1A-related epilepsies. Neurology 76:594–600
Chiron C (2011) Current therapeutic procedures in Dravet syndrome. Dev Med Child Neurol 53(Suppl 2):16–18
Caraballo RH, Cersosimo RO, Sakr D, Cresta A, Escobal N, Fejerman N (2005) Ketogenic diet in patients with Dravet syndrome. Epilepsia 46:1539–1544
Dutton SB, Sawyer NT, Kalume F, Jumbo-Lucioni P, Borges K, Catterall WA, Escayg A (2011) Protective effect of the ketogenic diet in Scn1a mutant mice. Epilepsia 52:2050–2056
Kasasbeh AS, Gurnett CA, Smyth MD (2014) Palliative epilepsy surgery in Aicardi syndrome: a case series and review of literature. Childs Nerv Syst : ChNS : official journal of the International Society for Pediatric Neurosurgery 30:497–503
Skjei KL, Church EW, Harding BN, Santi M, Holland-Bouley KD, Clancy RR, Porter BE, Heuer GG, Marsh ED (2015) Clinical and histopathological outcomes in patients with SCN1A mutations undergoing surgery for epilepsy. J Neurosurg Pediatr 16:668–674
Orosz I, McCormick D, Zamponi N, Varadkar S, Feucht M, Parain D, Griens R, Vallee L, Boon P, Rittey C, Jayewardene AK, Bunker M, Arzimanoglou A, Lagae L (2014) Vagus nerve stimulation for drug-resistant epilepsy: a European long-term study up to 24 months in 347 children. Epilepsia 55:1576–1584
Alexopoulos AV, Kotagal P, Loddenkemper T, Hammel J, Bingaman WE (2006) Long-term results with vagus nerve stimulation in children with pharmacoresistant epilepsy. Seizure 15:491–503
McInerney J, Siegel AM, Nordgren RE, Williamson PD, Thadani VM, Jobst B, Reeves AG, Roberts DW (1999) Long-term seizure outcome following corpus callosotomy in children. Stereotact Funct Neurosurg 73:79–83
Tanriverdi T, Olivier A, Poulin N, Andermann F, Dubeau F (2009) Long-term seizure outcome after corpus callosotomy: a retrospective analysis of 95 patients. J Neurosurg 110:332–342
Sunaga S, Shimizu H, Sugano H (2009) Long-term follow-up of seizure outcomes after corpus callosotomy. Seizure 18:124–128
Cersosimo RO, Bartuluchi M, Fortini S, Soraru A, Pomata H, Caraballo RH (2011) Vagus nerve stimulation: effectiveness and tolerability in 64 paediatric patients with refractory epilepsies. Epileptic Disord: international epilepsy journal with videotape 13:382–388
McHugh JC, Singh HW, Phillips J, Murphy K, Doherty CP, Delanty N (2007) Outcome measurement after vagal nerve stimulation therapy: proposal of a new classification. Epilepsia 48:375–378
Zamponi N, Passamonti C, Cappanera S, Petrelli C (2011) Clinical course of young patients with Dravet syndrome after vagal nerve stimulation. Eur J Paediatr Neurol: EJPN: official journal of the European Paediatric Neurology Society 15:8–14
Spatola M, Jeannet PY, Pollo C, Wider C, Labrum R, Rossetti AO (2013) Effect of vagus nerve stimulation in an adult patient with Dravet syndrome: contribution to sudden unexpected death in epilepsy risk reduction? Eur Neurol 69:119–121
Dressler A, Trimmel-Schwahofer P, Reithofer E, Muhlebner A, Groppel G, Reiter-Fink E, Benninger F, Grassl R, Feucht M (2015) Efficacy and tolerability of the ketogenic diet in Dravet syndrome—comparison with various standard antiepileptic drug regimen. Epilepsy Res 109:81–89
Fernandez L, Gedela S, Tamber M, Sogawa Y (2015) Vagus nerve stimulation in children less than 3 years with medically intractable epilepsy. Epilepsy Res 112:37–42
You SJ, Kang HC, Ko TS, Kim HD, Yum MS, Hwang YS, Lee JK, Kim DS, Park SK (2008) Comparison of corpus callosotomy and vagus nerve stimulation in children with Lennox-Gastaut syndrome. Brain Dev 30:195–199
Guillamon E, Miro J, Gutierrez A, Conde R, Falip M, Jaraba S, Plans G, Garces M, Villanueva V (2014) Combination of corpus callosotomy and vagus nerve stimulation in the treatment of refractory epilepsy. Eur Neurol 71:65–74
Cukiert A, Cukiert CM, Burattini JA, Lima AM, Forster CR, Baise C, Argentoni-Baldochi M (2013) Long-term outcome after callosotomy or vagus nerve stimulation in consecutive prospective cohorts of children with Lennox-Gastaut or Lennox-like syndrome and non-specific MRI findings. Seizure 22:396–400
Hauptman JS, Mathern GW (2012) Vagal nerve stimulation for pharmacoresistant epilepsy in children. Surg Neurol Int 3:S269–S274
Ciliberto MA, Limbrick D, Powers A, Titus JB, Munro R, Smyth MD (2012) Palliative hemispherotomy in children with bilateral seizure onset. J Neurosurg Pediatr 9:381–388
Sabaz M, Cairns DR, Lawson JA, Nheu N, Bleasel AF, Bye AM (2000) Validation of a new quality of life measure for children with epilepsy. Epilepsia 41:765–774
Conflict of Interest
The authors declare no conflict of interest.
Brian J. Dlouhy and Brandon Miller contributed equally to this work
About this article
Cite this article
Dlouhy, B.J., Miller, B., Jeong, A. et al. Palliative epilepsy surgery in Dravet syndrome—case series and review of the literature. Childs Nerv Syst 32, 1703–1708 (2016). https://doi.org/10.1007/s00381-016-3201-4
- Dravet syndrome
- Vagal nerve stimulation
- Corpus callosotomy